NCT03585192

Brief Summary

Late-preterm neonates are born between 34 and 36 weeks 7 days gestational age (GA). Neonates born less than 34 weeks GA are at increased risk for morbidity and directly admitted to the Neonatal Intensive Care Unit (NICU). Skin-to-skin contact (SSC) is a standard of care in many units to aid in post-natal transitioning. Current guidelines published by the Neonatal Resuscitation Program (NRP) and American Academy of Pediatrics (AAP) recommend only "vigorous, term" neonates initiate immediate SSC. There is no published data regarding safety or guidelines relating to late-preterm neonates and immediate SSC. Therefore, the investigators hypothesize that post-natal transitioning after immediate SSC within the first hours after birth will be no worse for vigorous, singleton 35 0/7 to 36 6/7 week neonates compared to those who transition to SSC after an initial period of 20 minutes observation under the radiant warmer.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2017

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 8, 2017

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

June 29, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 12, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
Last Updated

May 3, 2019

Status Verified

May 1, 2019

Enrollment Period

1.2 years

First QC Date

June 29, 2018

Last Update Submit

May 1, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Skin-to-skin interruptions

    The investigators will track the number of times skin-to-skin contact is disrupted within the first hour of life and document reasons for interruption.

    First hour of life

Secondary Outcomes (1)

  • Risks for late-preterm neonates

    Length of hospital stay

Study Arms (2)

Skin Group

EXPERIMENTAL

Pulse oximeter probe is placed on right wrist of vigorous neonate after vaginal birth. If randomized to skin group, neonate will initiate skin-to-skin contact after umbilical cord is cut and dried with warm blankets on Mother's abdomen. Length of monitoring will be for first hour of life.

Other: Skin Group

Warmer Group

ACTIVE COMPARATOR

Pulse oximeter probe is placed on right wrist of vigorous neonate after vaginal birth. If randomized to warmer group, neonate will initiate skin-to-skin contact after 20 minutes of observation under the radiant warmer. Length of monitoring will be for first hour of life.

Other: Warmer Group

Interventions

1. If the newborn is vigorous (crying, good respiratory effort, good tone) after vaginal delivery, newborn will be able to go directly to Mother's chest for immediate SSC 2. A pulse oximeter will be placed on the newborn's right wrist. Saturations will be monitored on a pulse oximeter located next to the Mother's bed for the first hour of life.

Skin Group

1. Newborn will go to the radiant warmer, pulse oximeter placed on newborn's right wrist, and saturations will be monitored on the Panda Warmer. 2. If stable per Baby RN after 20 minutes of observation, the newborn will be placed on Mother's chest for SSC. Vital signs will be monitored for the first hour of life.

Warmer Group

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Singletons born 35 0/7 to 36 6/7 weeks GA via vaginal delivery
  • Vigorous - crying, good respiratory effort, good tone
  • No major congenital malformation

You may not qualify if:

  • Neonates born \< 35 weeks GA
  • Non-vigorous or needing resuscitation soon after birth
  • Known major congenital malformation
  • Maternal sedation or if clinically unstable per Labor \& Delivery team

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UH Cleveland Medical Center

Cleveland, Ohio, 44106, United States

Location

Study Officials

  • Monika Bhola, MD

    UH Cleveland Medical Center MacDonald Women's Hospital

    PRINCIPAL INVESTIGATOR
  • Rebecca Walsh, MD

    UH Cleveland Medical Center MacDonald Women's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Neonatology Fellow, MD

Study Record Dates

First Submitted

June 29, 2018

First Posted

July 12, 2018

Study Start

November 8, 2017

Primary Completion

January 31, 2019

Study Completion

May 1, 2019

Last Updated

May 3, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations